A study on siddha trial drug Rajaloga naatharasa parpam(Int) Paruthi thylam(Ext) and Ottradam(External therapy) in patients having jointspai
Phase 2
- Conditions
- Health Condition 1: null- Uthiravadha suronitham(Rheumatoid arthritis)
- Registration Number
- CTRI/2018/05/013640
- Lead Sponsor
- Government Siddha Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Low grade fever
2.Morning stiffness >1hours
3.Arthritis of >=3 joint area of the possible 28
joints
4.Arthritis of hand joints[MCPs , PIPs ,
WRISTs]
5.Symmetric swelling â??same joints on both sides
6.Redness of joints
7.Rheumatoid nodules
8.Serum rheumatoid factor[RA factor]+ve or -ve
9.Anti ccp +ve
Exclusion Criteria
1.Systemic lupus erythematosis
2.Sub acute bacterial endocarditis
3.Rheumatic fever
4.Gouty arthritis
5.Carries spine
6.Ankylosing spondylitis
7.Psoriatic arthritis
8.Osteomyelitis
9.Renal failure
10.Tumours
11.History of long term intake of steroid
12.HIV
13.Progressive systemic sclerosis
14.Pregnancy&lactation
15.Chickungunya
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Primary outcome is mainly assessed by reduction in pain and inflammation of joints <br/ ><br>2.Reduction of morning stiffness <br/ ><br>3.Pain is assessed by universal pain assessment scale <br/ ><br>4.By comparing the any two parameters before and after treatment ESR, Hb, Anti-CCP, RA factor,CRP <br/ ><br> <br/ ><br>Timepoint: 12 months <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil